Cytokeratin CK 7 and CK 20 expression in pituitary adenomas

Endocrine Pathology

Volumn 16, Issue 3, 2005, Pages 201-210

  Coons, Stephen W ^a   Estrada, Sarah I ^a   Gamez, Ruben ^a   White, William L ^a  

^a BARROW NEUROLOGICAL INSTITUTE   (United States)

Author keywords

CK 20; CK 7; Fibrous bodies; Keratin; Pituitary adenoma

Indexed keywords

CYTOKERATIN 20; CYTOKERATIN 7; GROWTH HORMONE;

ARTICLE; CANCER CLASSIFICATION; CANCER GROWTH; COLON ADENOCARCINOMA; CONTROLLED STUDY; HORMONE RELEASE; HUMAN; HUMAN TISSUE; HYPOPHYSIS ADENOMA; IMMUNOHISTOCHEMISTRY; METASTASIS; PRIORITY JOURNAL; PROTEIN EXPRESSION;

ADENOMA; BIOLOGICAL MARKERS; CELL COUNT; HUMANS; IMMUNOHISTOCHEMISTRY; INTERMEDIATE FILAMENT PROTEINS; KERATIN-20; KERATIN-7; KERATINS; PITUITARY NEOPLASMS; RETROSPECTIVE STUDIES; TUMOR MARKERS, BIOLOGICAL;

EID: 28044472036     PISSN: 10463976     EISSN: None     Source Type: Journal    
DOI: 10.1385/EP:16:3:201     Document Type: Article

References (10)

1. Wang NP, Zee S, Zarbo RJ, Bacchi CE, Gown AM. Coordinate expression of cytokeratins 7 and 20 defines unique subsets of carcinomas. Appl Immunohistochem Mol Morphol 3:99-107, 1995.
2. Loy TS, Calaluce RD. Utility of cytokeratin immunostaining in separating pulmonary adenocarcinomas from colonic adenocarcinomas. Am J Clin Pathol 102:764-767, 1994.
3. Miettinen M. Keratin 20: immunohistochemical marker for gastrointestinal, urothelial, and merkel cell carcinomas. Mod Pathol 8:384-388, 1995.
4. Tot T. Adenocarcinomas metastatic to the liver: the value of cytokeratins 20 and 7 in the search for unknown primary tumors. Cancer 85:171-177, 1999.
5. Rullier A, Le Bail B, Fawaz R, Blanc JF, Saric J, Bioulac-Sage P. Cytokeratin 7 and 20 expression in cholangiocarcinomas varies along the biliary tract but still differs from that in colorectal carcinoma metastasis. Am J Surg Pathol 24:870-876, 2000.
6. Pernicone PJ, Scheithauer BW, Sebo TJ, et al. Pituitary carcinoma: a clinicopathologic study of 15 cases. Cancer 79:804-812, 1997.
7. O'Hara BJ, Paetau A, Miettinen M. Keratin subsets and monoclonal antibody HBME-1 in chordoma: immunohistochemical differential diagnosis between tumors simulating chordoma. Hum Pathol 29:119-126, 1998.
8. Coons SW, White WL, Feiz-Erfan I. Cytokeratin Ck7/Ck20. Profile in the evaluation of malignant progression and metastasis of a silent ACTH pituitary adenoma. J Neuropathol Exp Neurol 63:528, 2004.
9. Lloyd RV, Scheithauer BW, Kovacs K, Roche PC. The immunophenotype of pituitary adenomas. Endocr Pathol 7:145-150, 1996.
10. Asa SL. The pathology of pituitary tumors. Endocrinol Metab Clin North Am 28:13-43, v-vi, 1999.